0.07 - 0.07
0.04 - 0.15
840.0K / 2.59M (Avg.)
-2.33 | -0.03
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-28.08%
Negative revenue growth while 8028.HK stands at 9.32%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.01%
Negative gross profit growth while 8028.HK is at 211.81%. Joel Greenblatt would examine cost competitiveness or demand decline.
182.93%
EBIT growth above 1.5x 8028.HK's 69.21%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
82.95%
Operating income growth 1.25-1.5x 8028.HK's 55.98%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
167.65%
Net income growth above 1.5x 8028.HK's 51.89%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
163.64%
EPS growth above 1.5x 8028.HK's 52.11%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
163.64%
Diluted EPS growth above 1.5x 8028.HK's 52.11%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.52%
Share count expansion well above 8028.HK's 0.20%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.93%
Negative 10Y revenue/share CAGR while 8028.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-21.93%
Negative 5Y CAGR while 8028.HK stands at 290.51%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.93%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-100.00%
Negative 10Y OCF/share CAGR while 8028.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-77.48%
Negative 10Y net income/share CAGR while 8028.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-77.48%
Negative 5Y net income/share CAGR while 8028.HK is 21.40%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-77.48%
Negative 3Y CAGR while 8028.HK is 76.46%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
299.61%
Equity/share CAGR of 299.61% while 8028.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
299.61%
Equity/share CAGR of 299.61% while 8028.HK is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
299.61%
Positive short-term equity growth while 8028.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
We show growth while 8028.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-100.00%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-100.00%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-51.58%
We cut SG&A while 8028.HK invests at 6.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.